These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Distribution of acid mucopolysaccharides in connection with the topographic histological relationships in the medullary layer of the kidney]. Dubynin TL Arkh Anat Gistol Embriol; 1968; 55(9):56-8. PubMed ID: 4236274 [No Abstract] [Full Text] [Related]
8. Determination and differentiation of the nephron. Ekblom P Med Biol; 1981 Jun; 59(3):139-60. PubMed ID: 7311633 [No Abstract] [Full Text] [Related]
9. Lectins as fluorescence microscopic markers for saccharides in the human kidney. Holthöfer H; Virtanen I; Pettersson E; Törnroth T; Alfthan O; Linder E; Miettinen A Lab Invest; 1981 Nov; 45(5):391-9. PubMed ID: 6895394 [No Abstract] [Full Text] [Related]
10. [Behavior of Trasylol in the body as a model for the pharmacokinetics of basic polypeptides]. Habermann E; Arndts D; Just M; Räker KO; Török P Med Welt; 1973 Jul; 24(29):1163-7. PubMed ID: 4542586 [No Abstract] [Full Text] [Related]
11. [Proteoglycans-phospholipids interactions: roles in dentine mineralization]. Goldberg M; Chardin H; Septier D; Lecolle S C R Seances Soc Biol Fil; 1993; 187(2):210-22. PubMed ID: 8019902 [TBL] [Abstract][Full Text] [Related]
12. Observations on the early renal uptake and later tubular metabolism of radiolabelled aprotinin (Trasylol) in man: theoretical and practical considerations. Rustom R; Grime JS; Maltby P; Stockdale HR; Critchley M; Bone JM Clin Sci (Lond); 1993 Feb; 84(2):231-5. PubMed ID: 7679959 [TBL] [Abstract][Full Text] [Related]
13. [Protective action of Trasylol in experimental kidney disorders]. Truss F Anaesthesist; 1971 Aug; 20(8):293-9. PubMed ID: 5315174 [No Abstract] [Full Text] [Related]
14. Effects of lysine infusion on the renal metabolism of aprotinin (Trasylol) in man. Rustom R; Maltby P; Grime JS; Stockdale HR; Critchley M; Bone JM Clin Sci (Lond); 1992 Sep; 83(3):295-9. PubMed ID: 1382915 [TBL] [Abstract][Full Text] [Related]
15. Intraperitoneal administration of recombinant receptor-associated protein causes phosphaturia via an alteration in subcellular distribution of the renal sodium phosphate co-transporter. Yamagata M; Ozono K; Hashimoto Y; Miyauchi Y; Kondou H; Michigami T J Am Soc Nephrol; 2005 Aug; 16(8):2338-45. PubMed ID: 15976002 [TBL] [Abstract][Full Text] [Related]
16. Studies on the interaction of Trasylol (aprotinin) with trypsin-pancreatic secretory trypsin inhibitor (PSTI) complexes and with alpha 2-macroglobulin-trypsin-PSTI-complexes. Marks WH; Eddeland A; Ohlsson K Hoppe Seylers Z Physiol Chem; 1981 Dec; 362(12):1653-6. PubMed ID: 6172356 [TBL] [Abstract][Full Text] [Related]
17. Tubular absorption of filtered cystatin-C in the rat kidney. Roald AB; Aukland K; Tenstad O Exp Physiol; 2004 Nov; 89(6):701-7. PubMed ID: 15328307 [TBL] [Abstract][Full Text] [Related]
18. [Changes of kidney function and morphology during long-term infusion of high-dosage proteinase inhibitor (trasylol). Animal experimental findings]. Glaser E; Hey D; Neuhof H; Lasch HG Verh Dtsch Ges Inn Med; 1972; 78():1612-4. PubMed ID: 4541861 [No Abstract] [Full Text] [Related]